Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Launched by UNIVERSITY OF FLORIDA · Feb 24, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on helping cancer survivors and their family members or caregivers quit using tobacco products, such as cigarettes or e-cigarettes. The researchers want to create a program that not only supports cancer survivors in their journey to stop using tobacco but also includes training for healthcare providers. This training will help doctors and nurses ask patients about their tobacco use, advise them on quitting, and connect them to resources that can assist them. The goal is to make quitting easier for those affected by cancer and their loved ones.

To be eligible for this study, participants must be adults (18 years and older) who currently use tobacco products and either have a history of cancer or are currently receiving treatment for cancer at specific UF Health clinics. Informal caregivers, family members, or friends of cancer survivors who also use tobacco can join the study. Participants can expect to receive personalized support and resources to help them quit smoking, along with the healthcare provider training aimed at improving communication about tobacco cessation in cancer care. This is an important step toward better support for cancer survivors and their families in overcoming tobacco dependence.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cancer Survivors including Current Cancer Patients
• • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
• • Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment.
• • Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology).
• • Capable of completing study requirements
• • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
• • Adults aged ≥18 years
• • Informal Caregivers/Family Members of Cancer Survivors
• • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
• • A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above
• • Capable of completing study requirements
• • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
• • Adults aged ≥18 years
• Exclusion Criteria:
• • Cancer Survivors including Current Cancer Patients
• • Patients unable to complete the sessions because of language, travel or technology barriers
• • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
• • Informal Caregivers/Family Members of Cancer Survivors
• • Participants unable to complete the sessions because of language, travel or technology barriers
• • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.